Atlanta, GA, United States of America

Jian-Ming Li

This inventor holds 4 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignee: Emory University. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian-Ming Li. Retrieved from https://idiyas.com/inventor/jian-ming-li-1bpn6pv2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jian-Ming Li

Introduction

Jian-Ming Li is a prominent inventor based in Atlanta, GA, known for his significant contributions to the field of biomedical research. He holds a total of 4 patents that focus on innovative methods for managing cancer and viral infections. His work is characterized by a commitment to advancing medical science through the development of novel therapeutic approaches.

Latest Patents

Li's latest patents include groundbreaking research on compositions and uses of vasoactive intestinal peptide (VIP) antagonists. This disclosure relates to VIP antagonists for uses in managing the treatment or prevention of cancer and viral infections. In certain embodiments, it discusses chimeric variants of VIP antagonists and pharmaceutical compositions comprising these peptides. Additionally, the disclosure contemplates methods of stimulating immune cells to target cancer by mixing immune cells in vitro with the peptides and administering an effective amount of stimulated immune cells to a subject in need of cancer treatment. Another significant patent focuses on methods of treating cancer using cell-based therapies. This involves compositions and methods of reversing senescence in T cells by interrupting VIP signaling and/or inhibiting phosphatidylinositol-3-kinase (PI3 kinase) inhibitor signaling, which can be crucial in managing cancer and chronic viral infections.

Career Highlights

Jian-Ming Li is affiliated with Emory University, where he conducts his research and develops his innovative ideas. His work has garnered attention for its potential impact on cancer treatment and immune response modulation.

Collaborations

Li collaborates with esteemed colleagues such as Edmund K. Waller and Mohammad S. Hossain, contributing to a rich environment of research and innovation.

Conclusion

Jian-Ming Li's contributions to the field of biomedical research through his patents and collaborations highlight his role as a leading inventor in the fight against cancer and viral infections. His innovative approaches continue to pave the way for future advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…